Clare Hutton & Peter Colley
Hull & East Yorkshire Hospitals NHS Trust
Clare qualified in 2000 from University of Leeds with a BHSc (Hons) in Therapy Radiography. Commencing her career in London shortly returning to Hull where she had completed her clinical training and has continued to develop through her 18 year career. Clare was the lead Therapy Radiographer for IMRT, this interest led her to commence postgraduate education starting with a module specifically for IMRT; she was also awarded with a grant from her Trust to gain clinical experience in Palo Alto, San Francisco. Clare completed her PGDip in Radiotherapy & Oncology from Sheffield Hallam University in 2009. Clare has continued her postgraduate education and in 2015 graduated from the University of Leeds with an MSc in Leadership & Management in Health & Social Care which has helped her lead the radiotherapy service and recent IMRT advances in her current role as Radiotherapy Manager.
Peter is a registered Higher Specialist Scientist and the Consultant Physicist Lead for Radiotherapy Physics in Hull and has over 18 years of experience working in Radiotherapy Physics and with quality improvement systems. He has worked in various senior physics roles including the Oncology Information Systems Lead Principal Physicist, and the post of Principal Physicist Lead for Radiotherapy Treatment Planning, before moving into his current role.
The Implementation & Development of IMRT in Hull
The seminar will explain the local implementation and development of IMRT. Demonstrating how the service gained the 24% IMRT national target and how this has been sustained. The seminar will demonstrate the excellent MDT working relationships including the changes to patient specific QA to enable patients to commence treatment within 28 days. This will include the review of equipment replacement the service has experienced since the central investment in Radiotherapy equipment.
EVEN MORE SEMINARS
Khurum Khan Royal Marsden NHS Foundation Trust
Biomarkers of response and/or resistance to targeted therapies in refractory mCRC
Professor Farzin Farzaneh King’s College London
Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission
Professor Sun Myint Clatterbridge Cancer Centre (Private Clinic)
Rectal cancer- Do patients have a choice?
Stefan Schuster Datar Cancer Genetics Limited
Clinical Utility of Liquid Biopsy in Brain Tumors
Dr. Anna ME Bruynzeel Amsterdam UMC (formerly VUmc)
MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc